Insights from the NCORP Landscape Survey and a Roadmap for Healthcare Providers

A diagnosis of cancer during adolescence or young adulthood disrupts life at a pivotal developmental crossroads. Between the ages of 15 and 39, individuals are establishing financial independence, pursuing higher education, launching careers, or starting families. When cancer intervenes, it inflicts not only physical and psychological strain but also severe economic disruption—a clinical reality known as financial toxicity or cancer-related financial hardship.

A landmark study by Joanna M. Robles, MD, and colleagues, published in JCO Oncology Practice (2026), examines how community oncology practices across the United States identify and address financial distress among adolescents and young adults (AYAs). Utilizing data from the National Cancer Institute Community Oncology Research Program (NCORP) 2022 Landscape Assessment, this analysis evaluates 100 community oncology practices treating AYAs to uncover critical gaps in screening protocols and financial navigation infrastructure.

For oncologists, advanced practice providers (APPs), oncology nurses, social workers, and practice administrators, these findings present both a warning and a call to action.

Below is a deep dive into why financial toxicity in AYA oncology matters, who it affects most, and what changes community oncology practices must implement to deliver comprehensive, equitable care.

Why It Matters**

The High Stakes of Financial Hardship in AYA Oncology**

Financial hardship in cancer care is far more than an administrative or personal budgeting issue; it directly determines clinical outcomes, quality of life, and survival.

The Triad of Cancer-Related Financial Hardship**

Frameworks of financial toxicity define three interconnected domains:

• Material Hardship: Objective out-of-pocket medical expenses, medical debt, and lost wages due to treatment or job loss.
• Psychological Distress (Financial Distress): The emotional strain, anxiety, and worry caused by financial burden and economic uncertainty.
• Behavioral Coping Mechanisms: Non-adherence behaviors adopted to mitigate costs, such as skipping medication doses, delaying prescriptions, missing clinical appointments, or foregoing essential supportive care.

Direct Impact on Health Outcomes and Survival

More than 50% of AYAs with cancer report experiencing financial hardship, a significantly higher rate than older adult oncology populations. The clinical consequences of this burden are profound:

• Cost-Related Non-Adherence: AYAs experiencing treatment-related financial distress are markedly more likely to alter their treatment schedules, skip prescribed medications, or delay follow-up care compared to older adults.
• Impaired Quality of Life: High financial distress among AYA survivors correlates directly with worse physical functioning, lower cognitive function, and decreased self-efficacy.
• Barriers to Oncofertility Care: Financial strain frequently prevents AYAs from accessing fertility preservation services prior to gonadotoxic therapy, impacting long-term survivorship goals.
• Increased Mortality Risk: Extreme financial insolvency resulting in bankruptcy has been established as an independent risk factor for early mortality among patients with cancer.

“Targeting financial hardship during and after cancer treatment for AYAs has the potential to have a significant multifaceted impact on improving overall cancer care delivery and patient outcomes.” — Robles et al.

The Expanding “Screening-Intervention Gap”**

One of the most striking observations highlighted in the study is the widening divergence between academic recognition of financial toxicity and the implementation of practical solutions. While PubMed-indexed literature detailing cancer-related financial toxicity has exploded over the past decade, published research on financial screening and financial navigation interventions, particularly for AYAs, has remained almost flat.

Screening patients for financial distress without offering a structured, effective pathway for intervention creates an ethical dilemma for oncology providers. Clinicians identify acute socio-economic distress but often lack the specialized institutional resources required to relieve it.

Who It Affects**

Vulnerable Populations and the Community Practice Paradox**

To design effective solutions, healthcare providers must understand both patient-level risk factors and system-level disparities in resource allocation.

The Unique Vulnerability of Adolescents and Young Adults**

AYAs (ages 15–39) occupy a unique developmental spectrum that heightens their susceptibility to economic toxicity:

• Younger AYAs (Ages 15–29): Frequently financially dependent on parents, navigating high school or post-secondary education, and possessing minimal personal savings or independent credit history. For these patients, financial hardship impacts the entire family/household unit (dyadic financial strain).
• Older AYAs (Ages 30–39): Building careers, purchasing homes, and raising young children. A cancer diagnosis often leads to workplace absenteeism, reduced work hours, or total job loss, stripping them of employer-sponsored health insurance precisely when medical expenses peak.

Compared to older adults, AYAs generally have smaller financial reserves, less established credit, higher rates of underinsurance, and greater potential lifetime earnings loss due to disability.

The Role of Community Oncology Settings**

The vast majority of AYAs receive cancer care in community oncology settings rather than major academic or NCI-designated comprehensive cancer centers. Community facilities serve populations with elevated baseline risks for financial distress, including rural residents and underinsured individuals.

The 2022 NCORP Landscape Assessment compared 100 practices treating AYAs with 171 practices not treating AYAs, revealing distinct patient demographic profiles:

• Hispanic Patient Volume: 20.0% of AYA-treating practices served patient populations where ≥ 19% identified as Hispanic, compared to just 4.6% of non-AYA practices (p = 0.002).
• Non-English Language Volume: 30.0% of AYA-treating practices reported that ≥ 8% of patients spoke a language other than English, versus 5.7% of non-AYA practices (p < 0.001).
• Medicaid Coverage: 17.0% of AYA-treating practices had >30% of new cancer patients insured by Medicaid, compared to only 2.2% of non-AYA practices (p = 0.001).

Findings: The NCORP Landscape Data

The survey evaluated 271 NCORP practice groups across 45 NCORP sites (representing 517 discrete clinics). Among the 100 practices identified as treating AYAs, routine screening for financial distress was widely reported, but access to specialized support was strikingly limited:

• Screening Prevalence: 82.0% of practices reported routinely screening oncology patients for financial distress.
• Primary Navigation Method: 81.0% of practices relied on social workers to address financial needs.
• Cancer-Specific Financial Navigators: Only 47.0% of practices possessed a dedicated financial navigator or counselor specifically trained in oncology care.

NCORP Practice Infrastructure for Financial Distress

• Routine Financial Screening (82%)
• Social Worker Support (81%)
• Cancer-specific Navigator (47%)
• Billing Staff Assisting (46%)
• Non-cancer Financial Navigator (35%)
• Outside Case Management (31%)

The Inequity Paradox

The study unveiled a paradoxical disparity: practices treating patient populations at the highest structural risk for financial collapse had the least access to cancer-specific financial navigation.

Univariate analyses revealed significant inverse relationships:

1. High Medicaid Volume: Practices where >30% of patients were covered by Medicaid were significantly less likely to offer cancer-specific financial navigation compared to lower-Medicaid practices (6.4% vs. 26.4%; OR = 0.19, 95% CI: 0.05–0.71, p = 0.008).
2. Dedicated AYA Programs: Practices with formal, dedicated AYA programs were significantly less likely to offer dedicated cancer financial navigation than those without formal programs (10.6% vs. 28.3%; OR = 0.30, 95% CI: 0.10–0.91, p = 0.028).
3. Pediatric Oncology Programs: Practices affiliated with pediatric oncology programs were also less likely to have dedicated oncology financial navigators (21.3% vs. 49.1%; OR = 0.28, 95% CI: 0.12–0.68, p = 0.004).

These findings indicate that specialized AYA and pediatric clinics in community settings often lack the dedicated financial counseling infrastructure needed to match their psychosocial and clinical care capabilities.

What Changes**

A 4-Pillar Roadmap for Community Oncology Practices**

Addressing financial toxicity requires shifting from informal, ad-hoc interventions toward systematic, evidence-based practices. Practice leaders and clinical teams should implement changes across four key operational pillars:

The 4-Pillar Roadmap for Change

1. Implement validated, AYA-sensitive screening tools
2. Build dedicated, specialized financial navigation capacity
3. Deploy scalable, technology-enabled navigation models
4. Establish protocol-driven, longitudinal clinical pathways

Pillar 1: Implement Validated, AYA-Sensitive Screening Tools

Currently, financial distress screening relies heavily on general assessments. In the survey, 57.0% of practices identified financial distress via social worker evaluation, 38.0% via medical team questions, and 30.0% via patient-reported surveys. Among practices using patient surveys, 73.3% used the general NCCN Distress Thermometer.

• The Problem: The Distress Thermometer is a broad tool that lacks sensitivity and specificity for capturing true financial hardship. Remarkably, zero practices reported using validated financial toxicity screening instruments like the Comprehensive Score for Financial Toxicity (COST).
• The Clinical Change:
• Adopt Brief Validated Tools: Integrate validated, short-form screening instruments, such as 1- or 2-item abbreviated COST measures or the Impact of Cancer for Childhood Cancer Survivors (IOC-CS) scale, into routine Electronic Health Record (EHR) intake workflows.
• Assess Dyadic/Household Burden: For younger AYAs (ages 15–29), screening protocols must account for parental and household financial strain, engaging both the patient and family caregivers in assessments.

Pillar 2: Build Dedicated, Specialized Financial Navigation Capacity**

While 81.0% of practices utilize oncology social workers to address financial needs, social workers face wide-ranging responsibilities. Managing complex insurance pre-authorizations, co-pay assistance grants, foundation applications, and disability claims diverts time from essential psychosocial counseling. Furthermore, 46.0% of practices rely on billing staff, whose primary institutional focus is revenue collection rather than patient financial advocacy.

• The Clinical Change:
• Invest in Dedicated Personnel: Health systems must prioritize funding for specialized, cancer-specific financial navigators trained in co-pay relief programs, premium assistance, pharmaceutical manufacturer aid, and state/federal benefit programs.
• Reallocate Resources to High-Need Clinics: System administrators must address the navigation deficit in high-Medicaid and safety-net community practices where financial vulnerability is most acute.

Pillar 3: Deploy Scalable, Technology-Enabled Navigation Models**

In resource-constrained community settings where hiring dedicated full-time financial navigators is not immediately feasible, practices must leverage alternative modalities.

• The Clinical Change:
• Remote Financial Navigation: Partner with regional health networks or centralized tele-navigation hubs to offer virtual financial counseling.
• AI and Predictive Analytics: Implement EHR-based machine learning tools that analyze demographic and insurance data to flag patients at high risk for financial toxicity before treatment begins.
• Standardized Digital Toolkits: Distribute tailored, age-appropriate educational materials regarding health insurance literacy, loan deferment, and community grant options directly through patient portals.

Pillar 4: Establish Protocol-Driven, Longitudinal Clinical Pathways**

Financial distress is dynamic; it evolves across diagnosis, active treatment, transition to maintenance, and long-term survivorship. Screening once at intake is insufficient.

• The Clinical Change:
• Longitudinal Touchpoints: Establish mandatory screening intervals at specific treatment milestones: initial diagnosis, regimen changes, transition to survivorship, and annually thereafter.
• Automated Referral Triggers: Configure EHR systems so that a positive screen for financial distress automatically generates a work order for financial navigation, eliminating reliance on manual physician referrals.
• Interprofessional Integration: Embed financial navigators directly into multidisciplinary AYA tumor boards and clinical huddles alongside medical oncologists, nurse navigators, and social workers.

Moving from Awareness to Systemic Action**

The findings from the 2022 NCORP Landscape Assessment highlight a pivotal moment in AYA cancer care delivery. Oncology providers have successfully elevated awareness and routine screening for financial distress. However, screening without specialized intervention leaves young patients vulnerable to material hardship, treatment non-adherence, and compromised survival.

By shifting to validated screening instruments, expanding cancer-specific financial navigation infrastructure, and establishing equitable care pathways in community settings, the oncology community can ensure that surviving cancer as a young adult does not come at the cost of financial insolvency.

Reimagining Financial Care in AYA Oncology**

Reference

1. Robles JM, Ji L, Dressler EV, et al. Financial Distress Screening and Financial Navigation Among Adolescents and Young Adults Within the National Cancer Institute Community Oncology Research Program: Results of the 2022 Landscape Survey. JCO Oncol Pract. 2026;22(7):1216-1226. doi:10.1200/OP-25-00389